Philip Lambert
Technik-/Wissenschafts-/F&E-Leiter bei SATELLOS BIOSCIENCE INC.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Philip Lambert
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 18 | |
| Public Company | Pharmaceuticals: Major | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Philip Lambert
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Administrative Officer Director/Board Member | |
| QIAGEN N.V. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Financial Conglomerates | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Molecular Securities, Inc.
 Molecular Securities, Inc. Investment ManagersFinance Molecular Securities, Inc. provides investment banking services. The private company is based in New York, NY. | Investment Managers | Corporate Officer/Principal | |
TKT Europe-5S AB
 TKT Europe-5S AB Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., TKT Europe-5S AB is a Swedish company that markets, sells, and distributes pharmaceutical products. The company is based in Danderyd, Sweden. The company was founded by Jacob Nejtel Kaluski. TKT Europe-5S was acquired by Transkaryotic Therapies, Inc. on October 22, 2004 for $61 million. | Medical Distributors | Founder | |
| State University of New York College at Oneonta | College/University | Undergraduate Degree | |
| McMaster University | College/University | Undergraduate Degree Doctorate Degree | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
| University of Vienna | College/University | Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree | |
| Freie Universität Berlin | College/University | Corporate Officer/Principal | |
| The Johannes Gutenberg University of Mainz | College/University | Undergraduate Degree | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| Universität Rostock | College/University | Corporate Officer/Principal | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| The Baycrest Centre Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Bloom Burton & Co.
 Bloom Burton & Co. Investment Banks/BrokersFinance Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness. | Investment Banks/Brokers | Chief Executive Officer | |
Verio Therapeutics, Inc.
 Verio Therapeutics, Inc. BiotechnologyHealth Technology Part of Fate Therapeutics, Inc., Verio Therapeutics, Inc. is a Canadian pharmaceutical company that manufactures products for activating endogenous stem cells. The company is based in Ottawa, Canada. Verio Therapeutics was acquired by Fate Therapeutics, Inc. on April 08, 2010. The company was founded by Frank Gleeson, Michael Rudnicki. | Biotechnology | Founder Founder | |
| Bioimics AB | Director/Board Member | ||
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Medical/Nursing Services | Chief Operating Officer Chairman Director/Board Member Chief Executive Officer Chairman Director/Board Member | |
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Pulsetten AB | Director/Board Member | ||
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Biotechnology | Director/Board Member | |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| Stem Cell Network | Corporate Officer/Principal Chairman | ||
Grey Wolf Animal Health, Inc.
 Grey Wolf Animal Health, Inc. Agricultural Commodities/MillingProcess Industries Grey Wolf Animal Health, Inc. provides animal health products. The firm offers in-house development and the in-license of mature products. The company was founded by Ian Sandler in March 2015 and is headquartered in Toronto, Canada. | Agricultural Commodities/Milling | Chairman | |
| SALARIUS PHARMACEUTICALS, INC. | Biotechnology | Chairman | |
| Qing Bile Therapeutics, Inc. | Director/Board Member | ||
| Belina AB | Director/Board Member | ||
| The Albrecht Kossel Institute For Neuroregeneration | College/University | Director/Board Member | |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 16 |
| Kanada | 15 |
| Schweden | 11 |
| Deutschland | 7 |
| Schweiz | 3 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 9 |
| Finance | 8 |
| Commercial Services | 4 |
| Health Services | 3 |
Operativ
| Director/Board Member | 166 |
| Corporate Officer/Principal | 71 |
| Chairman | 65 |
| Chief Executive Officer | 30 |
| Founder | 25 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peer Schatz | 83 |
| Franklin Berger | 41 |
| Michael B. Cross | 15 |
| Geoff MacKay | 15 |
| Brian Bloom | 15 |
| Warren Whitehead | 14 |
| Adam Mostafa | 12 |
| Jacob Nejtel Kaluski | 12 |
| Andrin Oswald | 12 |
| Dirk H. Ehlers | 12 |
| William McVicar | 11 |
| Arndt Rolfs | 11 |
| Frank Gleeson | 10 |
| Jonathan Sheldon | 9 |
| Oved Amitay | 9 |
- Börse
- Insiders
- Philip Lambert
- Unternehmensverbindungen
